The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
NCT04358224
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Atopic Dermatitis
Eczema
Interventions
BIOLOGICAL:
Dupilumab Prefilled Syringe
Sponsor
Jonathan A. Bernstein, MD